With increasing pressure to get to market faster, many biopharma organizations have turned to telegenetics to support clinical trial enrollment, engagement and speed time-to-market. As they work to find and engage more people to enroll in studies, they’re operating in a changing landscape as trials become more decentralized and scientifically advanced. With value-added services such as genetic testing and counseling built into study protocols, biopharma companies not only benefit from knowing who qualifies for trials—but they also deepen their knowledge of the patient population and the genetic landscape for their therapeutics.

Join Genome Medical as they walk through these trends, discussing the role of telegenetics and how to build it into your research programs. You’ll learn:

1. How telegenetics can support patient identification, recruitment, and engagement to drive success and efficiency in clinical trials and sponsored testing programs
2. Proven strategies to integrate telegenetic services into product pipelines
3. Through insightful case studies, how two biopharma companies have used telegenetics in their programs